Isabella Graef is a board member and co-founder of Eidos Therapeutics. Isabella was previously employed at Stanford University.
Isabella Graef has a Master of Science in Microbiology and Immunology from the University of California, Berkeley and a Doctor of Medicine from the Medical School at the University of Vienna, Austria.